Please use this identifier to cite or link to this item:
https://saber.ucv.ve/jspui/handle/10872/14536Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Zabaleta, Mercedes | - |
| dc.contributor.author | Peralta, Jorge | - |
| dc.contributor.author | Birges, Julio | - |
| dc.contributor.author | Bianco Colmenares, Nicolás E. | - |
| dc.date.accessioned | 2017-02-21T00:08:04Z | - |
| dc.date.available | 2017-02-21T00:08:04Z | - |
| dc.date.issued | 1994 | - |
| dc.identifier.issn | 1525-4135 | - |
| dc.identifier.uri | http://hdl.handle.net/10872/14536 | - |
| dc.description.abstract | Human retroviruses, although recently identified, have been the focus of much attention since they are linked to neoplasia and chronic degenerative diseases. The human T-cell lymphotropic virus type I (HTLV-I), isolated in 1980, is the etiologic agent of human adult T-cell leukemia and HTLV-I associated myelopathy (HAM). In 1982, a second type of HTLV was described (HTLV-II); lately antibodies to HTLV-Il were found to be highly prevalent in IV-drug users. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Journal of Acquired Immune Deficiency Syndromes | en_US |
| dc.relation.ispartofseries | Vol. 7;No. 12 pp 1289-1290. | - |
| dc.subject | Human retroviruses | en_US |
| dc.subject | neoplasia | en_US |
| dc.subject | chronic degenerative diseases | en_US |
| dc.subject | T-cell lymphotropic | en_US |
| dc.subject | virus type I | en_US |
| dc.subject | (HTLV-I) | en_US |
| dc.subject | T-cell leukemia | en_US |
| dc.subject | myelopathy | en_US |
| dc.title | HTLV-I-Associated Myelopathy in Venezuela | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | Artículos Publicados | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Documento 56.pdf | 5.77 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.